世界のOTC医薬品産業ガイド

Abstract

Datamonitor' s OTC Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the OTC pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

• Contains an executive summary and data on value, volume and segmentation
• Provides textual analysis of the industry' s prospects, competitive landscape and profiles of the leading companies
• Incorporates in-depth five forces competitive environment analysis and scorecards
• Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US).
• Includes a five-year forecast of the industry

Highlights

The global OTC pharmaceuticals market grew by 4% in 2007 to reach a value of $84.8 billion.

In 2012, the global OTC pharmaceuticals market is forecast to have a value of $101.8 billion, an increase of 20.1% since 2007.

Cough and cold preparations form the most lucrative sector of the global market, with an 18.4% share of the market by value.

The Asia-Pacific is the leading region in the global market, with a 38.8% share of the total market value.

Pfizer Inc. is the leading company in the global market, with a 6.3% share of the market by value.

Pharmacies and drugstores form the most lucrative distribution channel, with a 67.2% share of the global market by value.

Why you should buy this report

• Spot future trends and developments
• Inform your business decisions
• Add weight to presentations and marketing materials
• Save time carrying out entry-level research

Market Definition

The OTC pharmaceuticals market values the total sales of analgesics, cough and cold preparations, indegestion preparations, topical OTC medicines, vitamins and minerals and other OTC healthcare products (anti-smoking aids, eye & ear drops, motion sickness medication, rectal medication and sleeping aids) at retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2006 annual average exchange rates.

For the purpose of this report the Americas comprises Brazil, Canada, Mexico and the US.

Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, the Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.

Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and Taiwan.

The global figure comprises the Americas, Asia-Pacific and Europe.

Table of Contents

List of Figures

CHAPTER 1 INTRODUCTION

• 1.1 What is this report about?
• 1.2 Who is the target reader?
• 1.3 How to use this report
• 1.4 Definitions

CHAPTER 2 Global OTC Pharmaceuticals

• 2.1 Market Overview
  • Research Highlights
  • Market Analysis
• 2.2 Market Value
• 2.3 Market Segmentation I
• 2.4 Market Segmentation II
• 2.5 Market Share
• 2.6 Five Forces Analysis
  • Summary
  • Buyer Power
  • Supplier Power
  • New Entrants
  • Substitutes
  • Rivalry
• 2.7 Leading Companies
  • Pfizer Inc
  • GlaxoSmithKline Plc
  • Novartis AG
• 2.8 Distribution
• 2.9 Market Forecasts
  • Market Value Forecast

CHAPTER 3 OTC Pharmaceuticals in Asia-Pacific

• 3.1 Market Overview
  • Research Highlights
  • Market Analysis
• 3.2 Market Value
• 3.3 Market Segmentation I
• 3.4 Market Segmentation II
• 3.5 Market Share
• 3.6 FIVE FORCES ANALYSIS
  • Summary
  • Buyer Power
  • Supplier Power
  • New Entrants
  • Substitutes
  • Rivalry
• 3.7 Leading Companies
  • Nin Jiom
  • Pfizer Inc
  • Novartis AG
• 3.8 Distribution
• 3.9 Market Forecasts
  • Market Value Forecast

CHAPTER 4 OTC Pharmaceuticals in Europe

• 4.1 Market Overview
  • Research Highlights
  • Market Analysis
• 4.2 Market Value
• 4.3 Market Segmentation I
• 4.4 Market Segmentation II
• 4.5 Market Share
• 4.6 Five Forces Analysis
  • Summary
  • Buyer Power
  • Supplier Power
  • New Entrants
  • Substitutes
  • Rivalry
• 4.7 Leading Companies
  • Bayer AG
  • Pfizer Inc
  • GlaxoSmithKline Plc
• 4.8 Distribution
• 4.9 Market Forecasts
  • Market Value Forecast
• 4.10 Macroeconomic Indicators

CHAPTER 5 OTC Pharmaceuticals in Belgium

• 5.1 Market Overview
  • Research Highlights
  • Market Analysis
• 5.2 Market Value
• 5.3 Market Segmentation I
• 5.4 Market Segmentation II
• 5.5 Market Share
• 5.6 FIVE FORCES ANALYSIS
  • Summary
  • Buyer Power
  • Supplier Power
  • New Entrants
  • Substitutes
  • Rivalry
• 5.7 Leading Companies
  • Pfizer Inc
  • Novartis AG
  • Omega Pharma NV
• 5.8 Distribution
• 5.9 Market Forecasts
  • Market Value Forecast
• 5.10 Macroeconomic Indicators

CHAPTER 6 OTC Pharmaceuticals in Canada

• 6.1 Market Overview
  • Research Highlights
  • Market Analysis
• 6.2 Market Value
• 6.3 Market Segmentation I
• 6.4 Market Segmentation II
• 6.5 Market Share
• 6.6 FIVE FORCES ANALYSIS
  • Summary
  • Buyer Power
  • Supplier Power
  • New Entrants
  • Substitutes
  • Rivalry
• 6.7 Leading Companies
  • Pfizer Inc
  • GlaxoSmithKline Plc
  • Jamieson Laboratories
• 6.8 Distribution
• 6.9 Market Forecasts
  • Market Value Forecast
• 6.10 Macroeconomic Indicators

CHAPTER 7 OTC Pharmaceuticals in China

• 7.1 Market Overview
  • Research Highlights
  • Market Analysis
• 7.2 Market Value
• 7.3 Market Segmentation I
• 7.4 Market Segmentation II
• 7.5 Market Share
• 7.6 FIVE FORCES ANALYSIS
  • Summary
  • Buyer Power
  • Supplier Power
  • New Entrants
  • Substitutes
  • Rivalry
• 7.7 Leading Companies
  • Johnson & Johnson
• 7.8 Distribution
• 7.9 Market Forecasts
  • Market Value Forecast
• 7.10 Macroeconomic Indicators

CHAPTER 8 OTC Pharmaceuticals in France

• 8.1 Market Overview
  • Research Highlights
  • Market Analysis
• 8.2 Market Value
• 8.3 Market Segmentation I
• 8.4 Market Segmentation II
• 8.5 Market Share
• 8.6 Five Forces Analysis
  • Summary
  • Buyer Power
  • Supplier Power
  • New Entrants
  • Substitutes
  • Rivalry
• 8.7 Leading Companies
  • Procter & Gamble Company, The
  • Sanofi-Aventis
  • Pfizer Inc
• 8.8 Distribution
• 8.9 Market Forecasts
  • Market Value Forecast
• 8.10 Macroeconomic Indicators

CHAPTER 9 OTC Pharmaceuticals in Germany

• 9.1 Market Overview
  • Research Highlights
  • Market Analysis
• 9.2 Market Value
• 9.3 Market Segmentation I
• 9.4 Market Segmentation II
• 9.5 Market Share
• 9.6 Five Forces Analysis
  • Summary
  • Buyer Power
  • Supplier Power
  • New Entrants
  • Substitutes
  • Rivalry
• 9.7 Leading Companies
  • Bayer AG
  • Pfizer Inc
  • GlaxoSmithKline Plc
• 9.8 Distribution
• 9.9 Market Forecasts
  • Market Value Forecast
• 9.10 Macroeconomic Indicators

CHAPTER 10 OTC Pharmaceuticals in Italy

• 10.1 Market Overview
  • Research Highlights
  • Market Analysis
• 10.2 Market Value
• 10.3 Market Segmentation I
• 10.4 Market Segmentation II
• 10.5 Market Share
• 10.6 FIVE FORCES ANALYSIS
  • Summary
  • Buyer Power
  • Supplier Power
  • New Entrants
  • Substitutes
  • Rivalry
• 10.7 Leading Companies
  • Boehringer Ingelheim GmbH
  • Bayer AG
  • GlaxoSmithKline Plc
• 10.8 Distribution
• 10.9 Market Forecasts
  • Market Value Forecast
• 10.10 Macroeconomic Indicators

CHAPTER 11 OTC Pharmaceuticals in Japan

• 11.1 Market Overview
  • Research Highlights
  • Market Analysis
• 11.2 Market Value
• 11.3 Market Segmentation I
• 11.4 Market Segmentation II
• 11.5 Market Share
• 11.6 Five Forces Analysis
  • Summary
  • Buyer Power
  • Supplier Power
  • New Entrants
  • Substitutes
  • Rivalry
• 11.7 Leading Companies
  • Pfizer Inc
  • Novartis AG
  • Wyeth
• 11.8 Distribution
• 11.9 Market Forecasts
  • Market Value Forecast
• 11.10 Macroeconomic Indicators

CHAPTER 12 OTC Pharmaceuticals in the Netherlands

• 12.1 Market Overview
  • Research Highlights
  • Market Analysis
• 12.2 Market Value
• 12.3 Market Segmentation I
• 12.4 Market Segmentation II
• 12.5 Market Share
• 12.6 FIVE FORCES ANALYSIS
  • Summary
  • Buyer Power
  • Supplier Power
  • New Entrants
  • Substitutes
  • Rivalry
• 12.7 Leading Companies
  • Bayer AG
  • Pfizer Inc
  • Procter & Gamble Company, The
• 12.8 Distribution
• 12.9 Market Forecasts